Glatiramer acetate treatment persistence - but not adherence - in multiple sclerosis patients is predicted by health-related quality of life and self-efficacy: a prospective web-based patient-centred study (CAIR study) User HealthEconBot, in the Health Economics Journal Articles subreddit, 15 Mar 2017